PCSA

$1.85-7.04%website ↗

Processa Pharmaceuticals, Inc.

Market Cap

$6M

Sector

Materials

Industry

Pharmaceutical Preparations

Beta

1.31

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

7 analysts

Velocity Score

28.48x

Current Rate (90d)

419.59/mo

Baseline Rate

69.24/mo

Unique Buyers (90d)

10

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-01	2026-07-01	Ng George K	Director & Chief Executive Officer	Purchase	3,057	$1.93	$6K	15.5K	View
2026-06-30	2026-07-01	SKIBSTED RUSSELL	Chief Financial Officer	Purchase	3,277	$1.93	$6K	16.7K	View
2026-06-30	2026-07-01	Guy Wendy	Chief Administrative Officer	Purchase	2,436	$1.93	$5K	14.4K	View
2026-06-30	2026-07-01	Lin Patrick	Chief Business - Strategy Off	Purchase	2,106	$1.93	$4K	13.1K	View
2026-06-30	2026-07-01	Young David	Director & Pres. Research & Development	Purchase	2,531	$1.93	$5K	21.7K	View

1–5 of 39

1 / 8

Recent News

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Yahoo · 2026-09-01

Processa Pharmaceuticals Acquires Vidya Therapeutics and Secures $200 Million Financing to Advance BTK Inhibitor Pipeline

Yahoo Finance · 2026-07-29

PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS

Yahoo Finance · 2026-07-29

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

Informational purposes only, not investment advice.